The goal of this collaboration is to identify the most promising antibodies, and increase their value by generating data that effectively de-risks each asset.
Read More
BIOQuébec welcomed the Québec government’s life sciences strategy which was unveiled earlier today, the contents of which will support the creation of value generated by the biotechnology and life sciences industry.
Read More
Support the Foundation to help it fulfill its important mission!
Read More
A great opportunity for companies in the life sciences industry.
Read More
Prevtec Microbia launches its third vaccine thanks to the support of its shareholders.
Read More
MOVANTIK is commercialized in Canada.
Read More
A BIOQuébec partner has issued its Opening the Door II labour market report.
Read More
The continuing development of Shigamab™ has been guaranteed. This transaction allows BELLUS Health to maintain financing for its activities until the end of 2018.
Read More
A 25% discount on the PetriDish™ job postings board is available to BIOQuébec members!
Read More
A pioneer in the fight against HIV/AIDS has passed away.
Read More
Submit the name of a candidate – an individual or a company - you feel deserves the award by April 30, 2017!
Read More
BIOQuébec is celebrating the Québec government’s newly introduced balanced budget for 2017-2018, which contains elements to support the value creation of the biotechnology and life sciences industry.
Read More
MassBio’s 2017 Annual Meeting is this week! Will you be attending?
Read More
BIOQuébec and Pharmed are hosting this forum on contract research organizations (CROs) in 2017. Benefit from a $100 discount off the regular price of $395!
Read More
The Institut national d’excellence en santé et services sociaux (INESSS) recommended to use an affordable genetic screening test to avoid cases where patients experience complications following the Xeloda chemotherapy treatment, commonly known as 5-FU in its intravenously administered form.
Read More
Morphine and Fentanyl addiction, the cause of hundreds of overdose deaths in the country, could become a thing of the past.
Read More
Immuno-oncology has become increasingly prominent in the medical research industry.
Read More
Pierre Falardeau, VP of BIOQuébec’s Board of Directors, will be a lecturer at GRUM’s 3rd Scientific Symposium.
Read More
The need for easier access to funding for SMBs was an increasingly popular topic in both politics and finance recently.
Read More
By June, GIPTIS will invite 10-12 companies to be part of its new public-private health organization and cooperation model in France.
Read More